ChemPartner PharmaTech Co.,Ltd.

¥8.55As of Sun 8 Nov 2026, 12:00 UTC
SZSE:300149Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (7.33%)
Div yield —
ROE (0.52%)
Biotechnology
Beta (5Y) 0.78
PE TTM —
TSR TTM (26.23%)
Mkt cap ¥4.318B
ROIC 2.81%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥9.53
11.44%
(76.73%)
Hold 6|3|7|2|12
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.11
0.11
0.11
0.12
5.34%
6.88%
(3.68%)
4.42%
Revenue¥M
370.5
372.8
364.9
358.3
10.18%
6.59%
2.73%
(4.11%)
Peers (US$647.2M)
Cap (US$)
PE
662.9M
18.20x
Capital
TTM
5Y
10Y
Leveragex
9.931
0.032
0.025
EBIT/Intx
1.080
0.200
0.145
Own earn%
288.22
(37.88)
9.03
Sh yield%
24.48
3.68
5.10
Owners
Insiders/Inst%
14.94
62.35
Short interest%
0.52
SBC / revenue%
5.15
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
14–18
$1 testx
−0.2
Incr. ROIC%
48